Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avidity Biosciences, Inc.

69.85
+0.16000.23%
Post-market: 69.850.00000.00%19:29 EDT
Volume:11.04M
Turnover:770.50M
Market Cap:10.27B
PE:-19.58
High:69.91
Open:69.73
Low:69.65
Close:69.69
52wk High:70.51
52wk Low:21.51
Shares:147.00M
Float Shares:113.00M
Volume Ratio:0.40
T/O Rate:9.77%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5671
EPS(LYR):-2.8885
ROE:-37.76%
ROA:-24.01%
PB:8.61
PE(LYR):-24.18

Loading ...

Avidity Biosciences downgraded to Market Perform from Strong Buy at Raymond James

TIPRANKS
·
Oct 27

Avidity Biosciences Inc : Needham Cuts to Hold From Buy Rating

THOMSON REUTERS
·
Oct 27

Avidity Biosciences Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
Oct 27

Why history shows this year's stock losers can be November winners

Dow Jones
·
Oct 27

Avidity Biosciences Inc : H.c. Wainwright Cuts to Neutral Rating; Cuts Target Price to $72

THOMSON REUTERS
·
Oct 27

Stocks to Watch Monday: Nvidia, MP Materials, Avidity -- WSJ

Dow Jones
·
Oct 27

Deals of the day-Mergers and acquisitions

Reuters
·
Oct 27

Avidity Biosciences Inc : Citigroup Cuts Target Price to $72 From $75

THOMSON REUTERS
·
Oct 27

U.S. Stocks to Watch: Avidity Biosciences, AMD, GameStop, Newmont, Microsoft, and More

Dow Jones
·
Oct 27

Avidity Biosciences Inc : Bernstein Cuts to Market Perform From Outperform; Raises Target Price to $72 From $52

THOMSON REUTERS
·
Oct 27

Novartis Deal Values Avidity Biosciences At $12 Billion

Dow Jones
·
Oct 27

Why Avidity Biosciences Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket

Benzinga_recent_news
·
Oct 27

Avidity Biosciences Shares Soar 42% Premarket After Novartis to Acquire Co for About $12 Bln

THOMSON REUTERS
·
Oct 27

Swiss stocks - Factors to watch on October 27

Reuters
·
Oct 27

Novartis to Acquire Avidity Biosciences for About $12 Billion

Reuters
·
Oct 27

Dow Jones Top Company Headlines at 9 PM ET: Novartis Agrees to Acquire Avidity Biosciences for $12 Billion | HSBC ...

Dow Jones
·
Oct 27

PRESS DIGEST- Financial Times - October 27

Reuters
·
Oct 27

BRIEF-Avidity Biosciences Says Spinco To Be Led By Kathleen Gallagher As Ceo

Reuters
·
Oct 27

Avidity Biosciences Enters Into Agreement to Be Acquired by Novartis Ag

THOMSON REUTERS
·
Oct 27

Avidity Biosciences Inc - Spinco to Be Led by Kathleen Gallagher as CEO

THOMSON REUTERS
·
Oct 27